NASH Epidemic: a call to action

NAFLD and NASH are common conditions with a rising burden. As pointed out by F. Kanwal et al. (Baylor College of Medicine, and Michael E. DeBakey Veterans Affairs Medical Center, Houston,
USA), “yet there are significant management gaps between clinical guidelines and practice in patients with NAFLD and NASH. Further, there is no single global guiding strategy for the management of
NAFLD and NASH.”
The American Gastroenterological Association, in collaboration with 7 professional associations, convened an international conference comprising 32 experts from the United States, Europe, Asia,
and Australia. The participants reviewed and discussed published literature on global burden, screening, risk stratification, diagnosis, and management of individuals with NAFLD and NASH.

Read More

NAFLD unawareness in US adults

S. A. Alqahtani et al. (King Faisal Specialist Hospital and Research Centre, Saudi Arabia; Johns Hopkins University, USA) aimed to understand public awareness of NAFLD and its temporal trends.
They included 11,700 adults from five National Health and Nutrition Examination Surveys (2007-2016).
From 2007-2008 to 2015-2016, awareness of liver disease among adults with NAFLD improved from 4.4% to 6.3%, but 4 to 10 times lower than awareness about viral hepatitis. In 2015-2016, among
adults with NAFLD, awareness of liver disease was low among young adults and among non-Hispanic Blacks.
Nearly 96% of adults with NAFLD in the USA were unaware they had liver disease, especially among young adults and non-Hispanic Blacks.

Read More